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 Programmed ribosomal frameshifting controls the ratio of two protein 
products made in a variety of viruses and mammalian cells. This occurs when the 
ribosome is translating mRNA, pauses at secondary structure, slips back one base in 
the 5’ direction, and continues translation in a new reading frame. A series of SARS-
CoV pseudoknot mutants were generated to examine important features of 
frameshifting, and an antibiotic was tested for its effect on HIV and SARS-CoV 
frameshifting. Other mutants were made in the human CCR5 gene to determine 
whether frameshifting occurs. It was found that mRNA stability and unpaired 
adenosines influence frameshifting, and increasing concentrations of the antibiotic 
gentamicin increases frameshifting. Moreover, CCR5, the co-receptor for HIV, 
contains a working frameshifting signal. This study pinpoints several antiviral targets 
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Chapter 1: Introduction- Ribosome Structure and Function 
 
 The process of translating messenger RNA (mRNA) to protein is fundamental 
in the cell, but it certainly isn’t simple. After genes are transcribed into mRNAs, the 
ribosome is responsible for converting the information contained in nucleotide 
sequences to amino acids to form proteins. Ribosomes are thus essential to all forms 
of life. The ribosome is a complex machine made up of RNA and protein. It consists 
of approximately 30% protein and 70 % RNA. The ribosome is made up of two 
different subunits that are required to work together to translate mRNAs.  
 Despite the fact that ribosomes are highly conserved, there are differences 
between the kingdoms. In bacteria, the subunits are called the 30S subunit, or the 
small subunit, and the 50S subunit, or the large subunit. When joined, they form a 
70S complex. In eukaryotes, the subunits are 40S (also known as the small subunit) 
and 60S (or large subunit), and come together to form an 80S complex. The RNA 
component in bacteria is made up of three species named 5S, 16S, and 23S. The large 
subunit contains the 5S and 23S rRNA and 33 proteins, while the small subunit is 
made up of the 16S rRNA and 21 proteins (Wilson & Nierhaus, 2003; Nilsson et al, 
2007). In eukaryotic ribosomes, the large subunit contains 45 proteins, 25S rRNA, 5S 
rRNA, and 5.8S rRNA (Nilsson et al, 2007). The small subunit is made up of 33 
ribosomal proteins and 18S rRNA.  
 Overall, eukaryotic ribosomes are about 30% larger than prokaryotic 
ribosomes (Wilson & Nierhaus, 2003). The differences lie in expansion segments of 
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rRNA, meaning that they contain additional sequence, and additional ribosomal 
proteins. Because of the conservation of functional centers, the differences are located 
mostly along the periphery of the ribosome.    
 The ribosome’s functional centers include three tRNA binding sites, known as 
the A, P, and E sites, decoding center, and peptidyltransferase center. These are all 
used throughout the steps of initiation, elongation, and termination, where each cycle 
adds a new amino acid. Approximately ten to twenty amino acids are added per 
second in the cell (Wilson & Nierhaus, 2003). As translation is responsible for 
making functional proteins, it is important to accurately decode the mRNA into 
protein. The error rate of translation in vivo is estimated to between 10-3 and 10-4 
(Ogle et al, 2005), which corresponds to one error in about 3000 codons (Wilson & 
Nierhaus, 2003). These errors are typically due to incorrect aminoacylation of tRNA, 
incorrect tRNA selection by the ribosome, or incorrect maintenance of the reading 
frame (Ogle et al, 2005). 
  
 Figure 1. Representation of the ribosome. The large and small subunit come 
together to carry out translation. Bound tRNAs are depicted in the diagram, as well as 
the mRNA and peptide channels. The peptidyl transferase center would be located 
directly above the A and P sites, while the decoding center is found on the small 
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subunit under the A site. 
(http://micro.magnet.fsu.edu/cells/ribosomes/images/ribosomesfigure1.jpg) 
 
 For initiation to begin, the ribosome must exist as separate subunits 
(Demeshkina et al, 2007). During resting phase or under stressful conditions, 
ribosomes are joined into 70S or 80S particles. Bacteria use elongation factor G and 
ribosome recycling factor to catalyze the dissociation of free 70S ribosomes. This is 
powered by GTP hydrolysis, although the dissociation is transient (Demeshkina et al, 
2007). IF3 is required to keep the subunits apart by binding to 30S subunits. IF3 is 
sufficient to split the 70S ribosomes, but is slow by itself. In eukaryotes, several 
eukaryotic initiation factors have activity similar to IF3, e.g. eIF1A, eIF1, and eIF3. 
eIF6 also has strong dissociation activity on 80S ribosomes. However, active 
dissociation of ribosomes is thought to be carried out by eEF2 in a process that 
requires ATP hydrolysis and is hindered by GTP (Demeshkina et al, 2007). The 
reaction is also transient and requires further stabilization by ribosome anti-
association factor or by treating the reaction with glutaraldehyde (Demeshkina et al, 
2007). 
 To begin initiation in bacteria, the mRNA has to bind the 30S subunit. The 
Shine-Delgarno sequence is complementary to the 3’ end of 16S rRNA and binding 
places the ribosome at the appropriate spot on the mRNA (Uemura et al, 2007; Ogle 
et al, 2005). Initiation factors IF1, IF2, and IF3 are all required for initiation. The 
initiator tRNA, Met-tRNAiMet, is bound to the P site. This initial binding is promoted 
by IF2 and stabilized by IF3 (Gualerzi et al, 1977).  The interactions between the 
Shine-Delgarno sequence and the ribosome also help stabilize the entire complex on 
the mRNA. There is a conformational change, and IF1 and IF3 are ejected from the 
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complex. IF2 then promotes binding of the 50S subunit (Laursen et al, 2005). 
However, after the first peptide bond is formed these interactions are relaxed, which 
allows for translocation of the ribosome (Uemura et al, 2007).  
 Eukaryotic initiation is much more complicated. eIF1, eIF1A, eIF3, and eIF5 
combine to form the multifactor complex (Fekete et al, 2007). All of these factors are 
required to recruit the 43S pre-initiation complex, which includes the initiator tRNA, 
Met-tRNAiMet, as a ternary complex with GTP and eIF2 bound to the 40S subunit. 
The entire complex binds to the mRNA and then scans to find the first AUG in a 
good context. The scanning process is stimulated directly by eIF1 and eIF1A. Their 
binding causes an open conformation in the small subunit that moves the head and 
platform of the 40S, and results in increasing accessibility of the mRNA channel 
(Gilbert et al, 2007). That allows for the scanning movement and restricts base 
pairing of non-AUGs with Met-tRNAiMet (Fekete et al, 2007). Once the AUG start 
codon binds the Met-tRNAiMet in the P site, eIF1 and eIF1A move apart from each 
other and eIF1 is released. This causes GTP hydrolysis and thus accommodation of 
the initiator tRNA. The resulting conformational changes and interaction with eIF5 
causes eIF1A to bind more tightly and restricts the mRNA channel so that scanning 
stops (Fekete et al, 2007). 
 After the initiator tRNA is bound and the 60S subunit has joined, the ribosome 
must decode the next codon of the mRNA. This process is broken up into two steps, 
decoding and accommodation. During decoding, the next aminoacyl-tRNA is brought 
to the ribosome as a ternary complex with GTP and EF-Tu in bacteria or eIF1A in 
eukaryotes. At this point the A site is in a low affinity state where interactions are 
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reduced with the ternary complex (Wilson & Nierhaus, 2003). Only the codon and 
anticodon interact with a small amount of discrimination energy.  
 The codon:anticodon interaction is monitored spatially by 16S rRNA bases in 
the A site. These bases include G529, G530, A1492, and A1493, which are all 
required for viability and tRNA binding (Ogle et al, 2005). When a cognate tRNA is 
in the A site, A1492 and A1493 are displaced into the minor groove of helix 44, and 
G530 switches from a syn to anti conformation. The first base pair between the codon 
and anticodon is monitored through a type I A-minor motif, while the second base 
pair is monitored by a type II A-minor motif (Wilson & Nierhaus, 2003; Ogle et al, 
2005). The second base pair is stricter than the first, but the third is not highly 
monitored. Hence the wobble position in codons. These interactions induce a 
conformational change that results in a global domain closure of the 30S shoulder 
(Ogle et al, 2005).  
 If there is incorrect binding, meaning the aa-tRNA is near-cognate or 
noncognate, these conformational changes do not occur and the aa-tRNA will diffuse 
out of the A site (Taliaferro & Farabaugh, 2007). The difference in binding rate 
constants are 100-fold, where the preference for cognate tRNAs are 10,000-fold 
greater. Also, the observed accuracy rates are due to the rate of activation of the 
GTPase and elongation factor (Taliaferro & Farabaugh, 2007). 
 This leads to the next step of accommodation. The domain closure leads to 
GTP hydrolysis, which provides the energy needed to relax the constrained anticodon 
stem loop of the distorted aa-tRNA, and release of EF-Tu. This allows the acceptor 
arm of the tRNA to “pop” into the peptidyltransferase center in the large subunit. 
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That means there has to be communication between the decoding center in the small 
subunit to the binding site of the ternary complex. This occurs through the tRNA 
body and intersubunit bridges (Cochella et al, 2007). Accommodation, then, is the 
rate-limiting step of aa-tRNA selection (Wilson & Nierhaus, 2003).  
 
 Figure 2. A schematic representation of tRNA selection during elongation on 
the ribosome. The first step shows decoding, while the second depicts 
accommodation. Red arrows show rates that are higher for near-cognate tRNA, 




 Immediately after accommodation, peptidyl transfer occurs. This requires the 
ribosome to have tRNAs in both the A and P site. The peptidyltransferase center 
(PTC) is located in the large subunit of the ribosome. The PTC is the catalytic site for 
transferring the nascent peptide chain from the peptidyl-tRNA in the P site to the 
aminoacyl-tRNA in the A site, thus growing the peptide chain by one amino acid. The 
catalytic center is made exclusively by rRNA and the mechanism is universally 
conserved (Wilson et al, 2005). There are no proteins within 15 Å of the active site, 
but ribosomal proteins are important for providing a framework and organizing the 
PTC.  (Bieling et al, 2006; Polacek & Mankin, 2005).  
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 The PTC is located at the bottom of the large cleft on the interface side of the 
large subunit underneath the central protuberance (Polacek & Mankin, 2005; Rodnina 
et al, 2006). The acceptor ends of the tRNAs meet at the bottom of the funnel-shaped 
active site above the entrance to the peptide exit tunnel, and are stabilized by the 23S 
rRNA (Polacek & Mankin, 2005). The P-tRNA bases C74 and C75 base pair with 
G2252 and G2251 of the 23S rRNA P-loop. The A-tRNA is fixed in position by 
pairing C75 with G2553 of the A-loop. Moreover, there are A-minor interactions 
between A76 and base pairs G2252-G2251 and A2450-C2501 (Rodnina et al, 2006). 
The flexibility of the ribosome allows an induced-fit mechanism to promote tight 
binding and orientation of the tRNAs (Davidovich et al, 2007). 
 The peptidyl transfer reaction consists of the α-amino group of the A-tRNA 
attacking the carbonyl group of the peptidyl residue of the P-tRNA. Thus the P-tRNA 
becomes deacylated and the A-tRNA gains the peptide (Wilson et al, 2005; Bieling et 
al, 2006; Polacek & Mankin, 2005). There are several possible ways to catalyze this 
reaction: abstraction or donation of protons, orientation and proximity effects, 
removing water from the active site, stabilizing the transition state by electrostatic 
interactions, and having a preorganized electrostatic environment which decreases the 
activation energy of the transition state (Bieling et al, 2006).  
 There has been much debate as to whether transpeptidation happens through 
an acid-base mechanism. Through many biochemical and mutational studies, it has 
been concluded this is not the case (Rodnina et al, 2006; Beringer & Rodnina, 2007).  
Currently the favorite model proposes that the ribosome catalyzes transpeptidation by 
reducing the entropy of the reaction by locking the tRNAs in the proper orientation, 
 
 8  
desolvation, and electrostatic shielding (Polacek & Mankin, 2005; Rodnina et al, 
2006). Peptidyl transfer occurs as a rate of 15-50 peptide bonds per second, which is a 
4x106 –fold acceleration compared to the uncatalyzed reaction (Bieling et al, 2006, 
Beringer & Rodnina, 2007).  
 After peptidyl transfer, there is a deacylated tRNA in the P site and a peptidyl-
tRNA in the A site. To continue the elongation cycle, translocation must occur to 
move the deacylated tRNA into the E site and the peptidyl-tRNA into the P site. All 
the interactions between the tRNAs, mRNA, and the ribosome, as well as intersubunit 
bridges, must be broken and then reestablished, while maintaining the correct reading 
frame. Movement from one site to another is a distance of 30Å (Munro et al, 2007). 
 Translocation is a complicated and dynamic process. First the translation 
factor EF-G in bacteria or eEF2 in eukaryotes binds to the ribosome after peptidyl 
transfer. This stabilizes the tRNAs in the so-called hybrid state, where the tRNA 
acceptor arms are in the next functional site in the large subunit while the anticodon 
stem loops remain in the classical position (Rodnina et al, 1999). For example, the A-
tRNA would move from the classical A/A state to the A/P hybrid state, with the 
acceptor arm in the P site and the anticodon in the A site (Pan et al, 2007; Li & Frank, 
2007). The P-tRNA moves from the P/P state to the P/E hybrid state. Binding of EF-
G/eEF2 also induces conformational rearrangements in the ribosome such that there 
is a ratcheting motion of the small subunit relative to the large subunit. This moves 
the anticodon stem loops of the tRNAs 8Å toward the next functional site (Taylor et 
al, 2007). Movement of the tRNAs enable domain IV of EF-G/eEF2 to reach into the 
A site and prevent backwards movement (Ortiz et al, 2006). GTP is hydrolyzed and 
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induces further conformational rearrangement, which leads to another 6Å shift of 
domain IV (Rodnina et al, 1999; Ortiz et al, 2006; Horan et al, 2007). The 
codon:anticodon interaction is thus broken, and allows the head of the small subunit 
to rotate. This moves the tRNAs the rest of the way into the respective E and P sites. 
EF-G/eEF2 then dissociates from the ribosome, which shifts back to its pre-
translocation state (Taylor et al, 2007). 
 Despite all the complicated steps, translocation is a fast process that is not 
rate-limiting to the elongation cycle. This is because GTP hydrolysis lowers the 
activation energy, but is not required to drive the reaction thermodynamically 
(Rodnina et al, 1999; Taylor et al, 2007).  
 Translocation results in binding a deacylated tRNA in the E site. Peptidyl-
tRNA or aminoacylated-tRNA cannot bind the E site (Wilson & Nierhaus, 2003). 
There are many interactions that hold the tRNA in place. In the small subunit, the 
rRNA joins with the ASL via backbone-backbone interactions, as well as the C-
terminal α helix of S7 (in bacteria) (Korostelev et al, 2006; Selmer et al, 2006). In the 
large subunit, the acceptor end of the tRNA makes backbone-backbone interactions 
with Helix 68, and touches ribosomal proteins L1 and L28 (Korostelev et al, 2006). 
The tRNA is further stabilized by base stacking (Selmer et al, 2006).  
 The E site stands for “exit” site. There cannot be more than two tRNAs on an 
active ribosome at one time so to continue the elongation cycle, the deacylated tRNA 
in the E site needs to be released (Wilson & Nierhaus, 2003; Dinos et al, 2005). This 
requires another translation factor in yeast, eEF3. eEF3 is specific to yeast, has 
ATPase activity, interacts with both subunits, competes with eEF2 for binding, and 
 
 10  
stimulates eEF1A-dependent binding of aa-tRNAs (Andersen et al, 2006). eEF3 has 
two domains that span the central protuberance of the large subunit and the head of 
40S. It binds specifically to the post-translocation state of the ribosome, 
simultaneously with eEF1A. Upon binding the ribosome, there is a conformational 
change that results in ATP hydrolysis and the dissociation of eEF3. The 
conformational change also relaxes the interactions that hold the E-tRNA in place, 
and that deacylated tRNA is released from the ribosome. This occurs when the aa-
tRNA has been decoded, but before GTP hydrolysis and accommodation (Dinos et al, 
2005).  
 As eEF3 is a specific elongation factor in yeast, it has been shown that in 
other eukaryotes and bacteria the E-tRNA is released upon movement of the L1 stalk 
due to conformational rearrangement of the ribosome when the ternary complex binds 
(Wilson & Nierhaus, 2006). There is no elongation factor necessary.  
 The final step in translation is termination, or nascent peptide release. When a 
stop codon on the mRNA is in the A site, release factors bind the ribosome. The tip of 
domain III of the release factor reaches into the peptidyl transferase center to promote 
hydrolysis of the peptidyl-tRNA ester bond (Polacek & Mankin, 2005). There is an 
activated water molecule that undergoes a nucleophilic attack on the carbonyl of the 
3’ terminal adenosine of the P-tRNA (Amort et al, 2007). This releases the peptide 
from the tRNA, and can thus exit the ribosome. If the reaction was uncatalyzed, 
termination would occur once in 14 hours (Polacek & Mankin, 2005). However, like 
peptidyl transfer, the reaction is entirely catalyzed by rRNA and thus the reaction 
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occurs approximately once per second (Polacek & Mankin, 2005; Beringer & 
Rodnina, 2007).  
 The PTC, then, has a dual role to play during translation. It has to perform 
catalysis of both transpeptidation and peptide release. Studies have shown that the 
23S rRNA base A2602 is important in both reactions. A2602 is a flexible base that is 
central in the PTC. It was hypothesized that A2602 coordinates and activates the 
water molecule that is responsible for the nucleophilic attack during termination only 
(Polacek & Mankin, 2005; Amort et al, 2007). However, there is a new model that 
predicts that the ribosome release factor in the A site orients A2602, and can act as a 
molecular switch. During termination, A2602 is pulled out of the center of the PTC to 
guide a water molecule into the active site (Amort et al, 2007). The 2’ hydroxyl of 
A76, then, could be responsible for coordinating and activating that water molecule.  
 
 
Figure 3. Summary 
of elongation cycle 
during bacterial 
translation using the 









(Dinos et al, 2005). 
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Chapter 2: Introduction- Programmed Ribosomal    
  Frameshifting in SARS-CoV and HIV 
 
 Programmed ribosomal frameshifting (PRF) is a mechanism that allows 
translation of a downstream open reading frame. This process is used by many RNA 
viruses, as a method to minimize genome space and to regulate the stoichiometry of 
protein products. Viruses are obligated to condense their genomes as much as 
possible due to space constraints in packaging the genome and time constraints during 
replication. It has been shown that many (+)ssRNA viruses, dsRNA viruses, plant 
viruses, and bacteriophages all utilize the frameshifting mechanism (Brierley & Dos 
Ramos, 2005). 
 In viruses, the frameshift signal is typically located between the structural 
genes and the enzymatic genes. The most common example is the gag gene, which 
encodes the protein necessary to build the capsid structure that packages the genome, 
and the pol gene, which encodes the polymerase that replicates the viral genome 
(Jacks et al, 1988; Dinman et al, 2002; Brierley & Dos Ramos, 2005). The ribosome 
will translate the gag gene, and the majority of the time it will terminate at the gag 0- 
frame stop codon. A certain proportion of the time, however, the ribosome will 
frameshift and slip into a new open reading frame. This allows the pol gene to be 
translated as a fusion peptide with the gag gene. The efficiency of the frameshift 
determines the ratio between the structural and enzymatic proteins.  
 If the frameshifting efficiency is changed, it can have dramatic effects on viral 
propagation (Dinman & Wickner, 1992; Léger et al, 2007). This was first shown with 
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the L-A virus, a dsRNA virus that infects yeast. There is a programmed ribosomal 
frameshift signal between the gag and pol genes. The L-A virus supports a satellite 
virus called M1, which encodes a toxin that kills surrounding yeast and thus confers a 
selective advantage to the host. The wildtype frameshifting efficiency is 1.9% so 
there are approximately 2 gag-pol fusion peptides per virion (Dinman & Wickner, 
1992). If the efficiency of frameshifting is changed, L-A cannot maintain M1, 
demonstrating that viral fitness is decreased.  
 This is also true for HIV-1. Similar to L-A, there is a frameshift signal 
between the gag and pol genes. Typical frameshifting efficiency is about 2 to 10% of 
the time, depending on what system is used to measure it (Jacks et al, 1988). When 
mutations were made in the slippery site or the stimulatory structure, frameshifting 
decreased (Jacks et al, 1988; Dulude et al, 2005; Plant & Dinman, 2006). 
Correspondingly, there was a decrease in activity of the polymerase and a decrease in 
infectivity (Dulude et al, 2005). This shows a direct correlation between frameshift 
efficiency and viral propagation. Thus frameshifting can be used as an antiviral target. 
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Decreased frameshifting efficiency = 
formation of empty viral particles.
Increased frameshifting efficiency = 




 Frameshifting has been found in retrotransposons and mammalian genes as 
well. In many neurodegenerative diseases insoluble protein aggregates are found. 
Examples of these proteins are ubiquitin B and β-amyloid precursor protein (Wills & 
Atkins, 2006). The aberrant forms of these proteins contain C-termini that are 
encoded by alternate reading frames. These proteins have been implicated in such 
diseases as Alzheimer’s, Huntington’s, and spinocerebellar ataxias, and it is 
hypothesized that the aberrant form is caused by frameshifting (Wills & Atkins, 
2006). 
 A programmed -1 ribosomal frameshift signal consists of three basic features: 
a heptameric slippery site, a spacer region of 6-9 nucleotides, and a downstream 
stimulatory structure. As the ribosome is translating, it pauses when it encounters the 
mRNA secondary structure (Takyar et al, 2005). The spacer region positions the 
Figure 4. Importance of 
frameshifting efficiency 
on viral propagation in 
terms of viral assembly.  
Increasing the amount of 
frameshifting leads to 
incomplete or unformed 
viral particles, whereas 
decreased frameshifting 
leads to empty viral 
particles. Both results in 
a decrease in viral 
infectivity.  
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ribosome over the slippery site during the pause. The slippery site motif is X XXY 
YYZ, where the spacing indicates the incoming reading frame. X can be any three 
identical nucleotides, Y can be AAA or UUU, and Z can be any nucleotide but G 
(Plant et al, 2003; Hansen et al, 2007; Léger et al, 2007). The stimulatory structure is 
typically a pseudoknot, although it has been shown that some stem loops can induce 
frameshifting.  
 Pseudoknots are a type of RNA secondary structure. These are formed when 
downstream sequence base pairs with the loop of a hairpin, although there are many 
variations on this theme (Puglisi et al, 1988). Pseudoknots have structural and 
functional roles, including the G-ribo motif pseudoknots in the ribosome (Steinberg & 
Boutorine, 2007). The stability of the pseudoknot is important for frameshifting 
efficiency: the more stable it is, the longer the ribosome pauses (Tu et al, 1992; Namy 
et al, 2006). However, there is no correlation between absolute frameshifting 
percentage and ∆G free energy (Giedroc et al, 2000; Hansen et al, 2007). 
 There are many different models as to how frameshifting occurs. The first 
proposes that the stimulatory structure acts as a binding site for a protein factor that is 
responsible for frameshifting (Brierley & Dos Ramos, 2005). However, no protein 
factor has ever been found, although this model can’t be ruled out. The second model 
suggests that the ribosome pauses at the stimulatory structure, which gives sufficient 
amount of time for the slip to occur (Tu et al, 1992). The emphasis on the importance 
of the RNA secondary structure is appropriate, but is not the sole determining factor 
(Namy et al, 2006). The third model is the simultaneous slippage model, where both 
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tRNAs bound to the A and P site re-base pair in the -1 frame (Jacks et al, 1988; Léger 
et al, 2007).  
 Within the simultaneous slippage model, there is debate as to when the 
frameshifting event happens during the elongation cycle. One argument is called the 9 
Å model. The pseudoknot interacts with the ribosome at the entrance to the mRNA 
channel. The ribosome has helicase activity located between the head and shoulder of 
the small subunit, and tries to unwind the pseudoknot (Jacks et al, 1988; Takyar et al, 
2005; Namy et al, 2006). This induces supercoiling and puts tension on the mRNA 
(Plant et al, 2003; Hansen et al, 2007). The model includes an occupied P site with an 
aminoacyl-tRNA that is being decoded in the A site, and exists in the hybrid A/T 
state. There is a 9 Å movement of the anticodon stem loop of the aa-tRNA during 
accommodation, but this movement is restricted by the tension on the mRNA due to 
being unable to unwind the pseudoknot and its blockage of the mRNA entrance 
tunnel (Plant et al, 2003; Namy et al, 2006; Hansen et al, 2007). The tension is 
relieved by having the tRNAs re-base pair in the -1 frame. This model, then, says that 
frameshifting occurs with a P-tRNA and an aa-tRNA that is not yet accommodated. 
Thus, it occurs before peptidyl transfer.  
 Another proposal is that frameshifting occurs during translocation. The 
elongation factor is bound to the ribosome and prevents binding to the A site until 
translocation and frameshifting occurs (Namy et al, 2006). The pseudoknot blocks the 
mRNA entrance channel and prevents accurate eEF2-catalyzed translocation (Plant et 
al, 2003). Instead of being able to shift the mRNA a complete codon, the mRNA is 
only moved two nucleotides. The added tension in the mRNA caused by the 
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stimulatory structure pulls on the P-tRNA towards the A site and raises the anticodon. 
Since the P-tRNA can’t return to the A site and translocation was incomplete, the 
strain on the tRNAs cause breakage and rebinding of the codon:anticodon in the -1 
direction (Namy et al, 2006). One of the attractive points of this model is that fact that 
GTP hydrolysis supplies the energy for the breaking and reforming of the hydrogen 
bonds between the tRNAs and mRNA (Plant et al, 2003). 
 The other arugment proposes that frameshifting happens before translocation. 
tRNAs that are in the hybrid state can unpair from the mRNA, move one base in the 
upstream 5’ direction, and re-pair. The anticodon stem loops can then move with the 
mRNA to the P and E sites (Léger et al, 2007).  
 The above two models have been integrated to propose that frameshifting is 
triggered by incomplete translocation, and happens, then, after peptidyl transfer. The 
tRNAs are in the hybrid state, where acceptor stems are in an intermediate position 
between the PRE and POST states of the translocated ribosome. The anticodon stem 
loops move to the classical E/E and P/P sites, which drag the mRNA by 1 codon. 
However, some mRNAs can only drag the mRNA by 2 bases due to the constraint of 
being unable to unwind the RNA secondary structure downstream. Thus, the tRNAs 
are block in intermediate sites, and the incoming aa-tRNA is blocked as well. 
Therefore, the interactions between the codons and anticodons break and re-form, 
starting in the E site. This causes an overall change in the reading frame in the -1 
direction (Léger et al, 2007).  
 
 




Pseudoknot melted out, 
translocation occurs, 
translation resumes in -1 
frame




XXY   YYZ
X XXY   YYZ
tRNAs slip 1 base in -1 






 Figure 5. Mechanism of -1 Programmed Ribosomal Frameshifting. As the 
ribosome translates certain mRNAs, it pauses when it encounters a stable secondary 
structure, typically a pseudoknot. The bound tRNAs uncouple from the mRNA and 
repair in the -1 frame. Then the pseudoknot is unwound and translation continues in 
the -1 open reading frame. 
 
 
 It is important to point out that these models for ribosomal frameshifting do  
 
not have to be mutually exclusive. 
 
 Regardless of when frameshifting occurs during translation, other factors are 
important for determining if frameshifting occurs and its efficiency. The sequence of 
the slippery site can have a profound impact (Plant & Dinman, 2006; Hansen et al, 
2007). Some slippery sites are more “slippery” than others, particularly 
homopolymeric sequences and those without Gs or Cs (Brierley & Dos Ramos, 2005; 
Namy et al, 2006). These are nucleotides that have more hydrogen bonds and thus 
require more energy to break the codon:anticodon interactions. The nucleotide 
 
 19  
sequence surrounding the slippery site can also influence frameshifting (Brierley & 
Dos Ramos, 2005; Hansen et al, 2007).  
 As previously mentioned, the stability of the pseudoknot impacts the 
frameshifting efficiency. The less stable a pseudoknot or secondary structure is, the 
less frameshifting occurs. The ability of the pseudoknot to resist unwinding by the 
ribosome and the energy barriers to unfolding the pseudoknot are both factors of 
efficiency (Plant & Dinman, 2005). Modifications to the tRNAs in the A and P site 
can affect the stability of the codon:anticodon interactions and change the 
frameshifting efficiency (Plant & Dinman, 2006). Also, mutations in the E site or 
rRNA in the platform of the small subunit can affect frameshifting (Léger et al, 
2007). In general, structural changes to the ribosome can have a profound impact. 
 Human Immunodeficiency Virus (HIV) is the etiological agent of AIDS. It is 
a (+)ssRNA virus that is a member of the Retroviridae family. There are two copies 
of its 9kb genome packaged together into virions through a kissing loop interaction. 
The helical nucleocapsid also contains 50-100 copies each of reverse transcriptase, 
integrase, and protease. HIV infects certain immune cells by binding to the CD4 and 
CCR5 receptors through its envelope protein gp120 (or SU/TM). Fusion of the viral 
envelope with the cell membrance allows the viral capsid to enter the cytoplasm, 
where it undergoes reverse transcription. The enzyme reverse transcriptase converts 
the RNA genome into cDNA, which is transported into the nucleus and integrated 
into the host genome. The viral proteins are produced through host transcription and 
translation, similarly to new genomes being made through transcription. Virions are 
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assembled at the cell membrane, where they exit by budding. Maturation occurs after 
budding and produces infectious virus. 
 The viral structural protein that is responsible for forming the capsid is called 
Gag, and is located on the 5’ end of the genome. Gag overlaps with the pol gene, 
which encodes the reverse transcriptase, protease, and integrase (Jacks et al, 1988; 

















 Figure 6. Genomic organization of HIV. The gag and pol genes overlap so 
there must be a frameshift signal that directs translation of the pol gene. The majority 
of the time just the gag structural protein is made, but when a frameshift occurs the 
Gag-pol fusion protein is generated. 
 
 
 Studies on the HIV frameshift signal have shown that the frameshift occurs 
between two and ten percent of the time (Girnary et al, 2007). That means there is a 
Gag to pol ratio between 20:1 and 60:1 (Dinman et al, 2002). As previously 
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mentioned, maintaining the stoichiometry between the structural and enzymatic 
proteins is crucial for viral propagation. The slippery site is U UUU UUA, where the 
spacing indicates the incoming reading frame, and is universally conserved among 
HIV isolates (Dinman et al, 2002; Brierley & Dos Ramos, 2005; Girnary et al, 2007). 
Unlike SARS-CoV, the slippery site is located 200 nucleotides upstream of the gag 
stop codon (Brierley & Dos Ramos, 2005).  
 The stimulatory structure of the HIV frameshift signal has been highly 
debated. Many different structures have been proposed to be the cause of 
frameshifting. It has been shown and accepted that the solution structure of the 
stimulatory structure is a highly stable stem loop (Stable & Butcher, 2005; Brierley & 
Dos Ramos, 2005). There is a purine bulge that interrupts the stem loop. It is unusual 
to have a stem loop stimulate frameshifting and is the exception that the stimulatory 
structure is a pseudoknot (Dinman et al, 2002). However, the slippery site resides at 
the base of the stem loop so it has been proposed that the ribosome unwinds the lower 
stem as it translates the mRNA (Léger et al, 2007). This would place the slippery site 
in the A and P sites of the ribosome so the upper stem, then, would act as the 
stimulatory structure. The 3’ half of the lower stem would be free to come back and 
base pair with the upper stem, forming a triplex (Dinman et al, 2002). It has been 
suggested that there is a conformational equilibrium between the two positions, and 
the actual structure that promotes frameshifting is the triple helix. 
 





 In November 2002, there was an outbreak of a new disease in Guangdong 
Province of China. By February 2003, it had moved to Hong Kong and further spread 
to over twenty-five other countries (Thiel et al, 2003; Brierley & Dos Ramos, 2005). 
The disease was called severe acute respiratory syndrome, or SARS. It was marked 
by fever, dyspnea, lower respiratory tract infection and gastrointenstinal symptoms 
(Rota et al, 2003; Weiss & Navas-Martin, 2005). By July 2003, the outbreak had been 
controlled through patient isolation and was considered over (Brierley & Dos Ramos, 
2005; Weiss & Navas-Martin, 2005). There were over 8,000 cases of SARS 
worldwide and over 800 deaths. 
 The global attention on the outbreak spurred international research, and it was 
announced on March 24, 2003 that SARS was caused by a new human coronavirus, 
called SARS-CoV (Rota et al, 2003). As a member of the coronavirus family, it is a 
(+)ssRNA virus with a genome of 29.7 kb (Rota et al, 2003; Thiel et al, 2003; 
Figure 7. Solutions of 
the HIV frameshift 
stimulatory signal.  
 
The left stem loop is 
the solution structure 
solved by NMR 
(Stable & Butcher, 
2005). The structure 
on the right is the 
triplex that could form 
when the bottom stem 
is melted by the 
ribosome (Dinman et 
al, 2002). The slippery 
site is underlined. 
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Brierley & Dos Ramos, 2005). It is an enveloped virus that infects cells by attaching 
its spike protein to the angiotensin-converting enzyme 2 receptor (Weiss & Navas-
Martin, 2005). The binding induces a conformational change that allows fusion of the 
viral envelope with the host cell membrane, and the nucleocapsid can enter the 
cytoplasm. Here SARS-CoV can have its genome translated, as its genome can also 
function as mRNA. Once the RNA-dependent RNA polymerase (RDRP) has been 
synthesized, replication of the viral genome also begins. It is believed that SARS-
CoV assembles at the Golgi intermediate compartment, and the envelope is acquired 
by budding into vesicles. The vesicles ship the viral particles to the cell surface, 
where they exit the cell for further infections. 
 SARS-CoV has a genomic organization where the replicase gene is located at 
the 5’ 22kb (Rota et al, 2003; Thiel et al, 2003; Weiss & Navas-Martin, 2005). Then 
the structural genes are encoded: spike, envelope, membrane, and nucleocapsid 
proteins (Rota et al, 2003; Thiel et al, 2003; Brierley & Dos Ramos, 2005). The 
structural proteins are made through subgenomic mRNAs, while the replicase gene is 
translated in two parts through a frameshift mechanism (Thiel et al, 2003).  
 During typical translation, the 5’ end of the replicase gene is translated only, 
known as orf1a. Approximately 14 to 28% of the time, orf1b is also translated to 
generate the polyprotein orf1ab (Thiel et al, 2003; Brierley & Dos Ramos, 2005; 
Weiss & Navas-Martin, 2005). Orf1a is processed into eleven proteins by two 
cysteine proteases (Thiel et al, 2003). Orf1b is processed into five proteins, including 
the RDRP, helicase, exonuclease, endoribonuclease, and a methyltransferase (Thiel et 
al, 2003; Brierley & Dos Ramos, 2005). The frameshift signal was discovered to 
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contain all the expected features- a slippery site, a spacer region of seven nucleotides, 
and a downstream pseudoknot (Thiel et al, 2003; Su et al, 2005). The slippery site of 
the frameshift signal was determined to be U UUA AAC (Baranov et al, 2005; Plant 
et al, 2005; Su et al, 2005), and is found twelve nucleotides upstream from the orf1a 
stop codon.  
 
 
Figure 8. Organization of SARS-CoV replicase gene. Orf1ab encodes sixteen proteins 
that are important for viral replication and pathogenesis, including the RNA-
dependent RNA polymerase in orf1b. The orf1ab fusion protein is only made through 
a ribosomal frameshift, which is located only twelve nucleotides upstream from the 
orf1a stop codon. 
 
 
 Studies on the SARS-CoV frameshift signal have characterized the 
pseudoknot as a unique three-stemmed pseudoknot (Plant et al, 2005). Early studies 
initially showed a typical H-type pseudoknot, but computational, molecular, 
biophysical, and genetic evidence have shown the presence of a third stem-loop 
(Thiel et al, 2003; Plant et al, 2005).  
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 Figure 9. Structure of SARS-CoV pseudoknot. On the left is the original 
proposed structure of the SARS-CoV pseudoknot, while on the right is the accepted 
structure (Thiel et al, 2003; Plant et al, 2005). Take note of the stem and loop labels 
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Chapter 3: Results 
 
Part 1: SARS-CoV Frameshifting 
 To further glean information and insight into SARS-CoV frameshifting, a 
series of mutants were made in the frameshift signal. The first set of mutants 
examined the gross structure of the SARS-CoV pseudoknot, looking at each structural 
unit’s contribution to frameshifting. Previous studies have already shown that 
changes to the slippery site change the frameshifting efficiency, as do changes to the 
distance between the slippery site and the pseudoknot (Baranov et al, 2005; Su et al, 
2005).  
 Other structural studies have already pointed out some of the key structural 
elements of the pseudoknot. Total disruption of either stem 1 or stem 2 causes a ten to 
twenty- fold decrease in frameshifting (Baranov et al, 2005; Plant et al, 2005). 
Disruption of stem 3 seems to have a variable effect. Furthermore, there are two 
bulged As in the pseudoknot that seem to be important for frameshifting.  
 The first set of mutants examined stem 2, stem 3, loop 2, and the stem 2 
bulged A, as seen in Figure 10. When the base pairing of stem 3 was disrupted, 
frameshifting was severely decreased. Then the structure of stem 3 was maintained, 
but certain base pairs were switched out. Frameshifting still decreased from 15.4% to 
5.5%, suggesting that the sequence of stem 3 might be important and not just the 
structure. When loop 2 was mutated to an asymmetric loop, frameshifting decreased 
by approximately 30%. Furthermore, the unpaired adenosine in stem 2 was mutated 
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to a cytosine. Frameshifting consequently decreased to about 1.5%. This corresponds 
to another mutant where that nucleotide was deleted, which resulted in almost no 
frameshifting (Plant et al, 2005). Finally, stem 2 base pairing was interrupted and 




% PRF 15.4 5.50 2.78 4.66 1.43 0.38
St. Err. 0.455 0.1897 0.1003 0.1512 0.0663 0.0307
  
 
 Figure 10. Gross structural mutations in the SARS-CoV pseudoknot. 
Mutations are highlighted by gray boxes. The frameshifting efficiency is denoted by 
%PRF and percent standard error is reported underneath the construct designation. 
Data was collected in two individual experiments until a normal distribution was 
established, allowing statistical analyses across and between experiments (Jacobs & 
Dinman, 2004). 
 





































Figure 11. Frameshifting of gross structural mutants in the SARS-CoV pseudoknot. 
Absolute values of frameshifting efficiencies are graphed for comparison. Error bars 




 The effect of loop 2 mutations and the change in frameshifting efficiency 
caused by the bulged A’s required further investigation, as evidenced by Figure 10. It 
was noticed that the symmetric loop 2 allowed base pairing with another loop 2, as in 
a kissing loop interaction. This could be influential in frameshifting. Therefore, loop 
2 was mutated to a tetraloop, which prevents the possible kissing loop interaction, as 
well as increases the stability of the pseudoknot. Increased stability would be 
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GC           A
5’ CGGCA-CAG  ACUAGU CUG UGUCG 3’
3’ GCUGU GUC  UGAUCA  GAC-ACGGC 5’







Figure 12. Possible kissing loop interaction between two SARS-CoV pseudoknots. 
Panel A shows the loop 2 of SARS-CoV pseudoknot. Panel B demonstrates the 
possible base pairing between two loop 2s, while Panel C shows extended base 




 As previously mentioned, there are two bulged A’s that seem to be important 
for frameshifting. When the stem 2 unpaired adenosine was either deleted or mutated 
to a C, frameshifting was negligible (Plant et al, 2005). More deletions were made of 
these unpaired bases, separately and in conjunction with each other. Depictions of 
these mutants can be seen in Figure 13. The loop 2 mutations were also generated 
with deletions of the bulged As. Another SARS-CoV mutant was made that 
investigated the importance of pseudoknot stability. Stem 3 was shortened to only 
two base pairs and loop 2 was replaced with a tetraloop. This should increase the 
overall stability of the pseudoknot, and would be predicted to increase frameshifting 
like the loop 2 mutant. 
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% PRF 15.60            20.44 1.47 18.77               8.75 12.99   
St. Err  0.10 0.671 0.077         0.170 0.437 0.545
 
Figure 13. SARS-CoV pseudoknot mutants looking at deleted bulged adenosines or 
pseudoknot stability. Mutated bases are highlighted by gray boxes, whereas deleted 
bulged As are not depicted. Frameshifting efficiency is denoted by % PRF and 
standard error is shown. Data was collected in four individual experiments until a 
normal distribution was established, allowing statistical analyses across and between 
experiments (Jacobs & Dinman, 2004). 
 
 These mutations had a broad range of effects on frameshifting. When the 
unpaired adenosine was deleted from S3C frameshifting increased by about 30%. 
However, when both unpaired adenosines were deleted, in the S23C mutant, 
frameshifting dropped to about 1.5%. This could mean that only the stem 2 bulged A 
is important, but further investigation is needed. The stable tetraloop that was made in 
loop 2 (L2*) showed increased frameshifting, which correlates to mRNA stability. 
Another mutant had the tetraloop and the stem 2 unpaired nucleotide deleted, S2C*, 
and frameshifting was about half of wildtype level. The shortened stem 3 with a 
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tetraloop, S3_2bp_CUUG, had a frameshifting efficiency of 13%, which was close to 
wildtype. 



















Figure 14. Frameshifting effects of deleted unpaired adenosines and mRNA stability  
in the SARS-CoV pseudoknot. Absolute values of frameshifting efficiencies are 




 One group of investigators found that SARS-CoV has a so-called attenuator 
region upstream of the frameshift signal. It was discovered by including an additional 
150 bases 5’ of the pseudoknot into their dual luciferase construct. When they 
measured frameshifting, they found that frameshifting decreased by about 50% in 
comparison to the wildtype construct that contained just the frameshift signal (Su et 
al, 2005). It was then proposed that this highly structured region might somehow 
interact with the ribosome or downstream sequence to attenuate frameshifting 
efficiency. 
 






Figure 15. SARS-CoV attenuator region and sequence. The top panel shows the 
predicted structure of the attenuator region, located 150 bases 5’ of the frameshift 
signal. Panel B displays the nucleotide sequence of the attenuator, with the amino 
acid sequence designated above with single letter abbreviations. Underneath the 
sequence, nucleotide substitutions are written that would affect base pairing in the 
attenuator, but preserve the amino acid sequence. 
 
  




 C   D   L   K   G   K   Y   V   Q   I   P   T   T   C   A   N   D   P 
TGT GAC TTG AAA GGT AAG TAC GTC CAA ATA CCT ACC ACT TGT GCT AAT GAC CCA 
  C                   A               C       A   C       A       T 
  
 V   C   F   T   L   R   N   T   V   C   T   V   C   G   M   W   K   G 
GTG GGT TTT ACA CTT AGA AAC ACA GTC TGT ACC GTC TGC GGA ATG TGG AAA GGT 
  C   C       C           T       G               T   C       T       C 
 
 Y   G   C   S   C   D   Q   L   R   E   P   L   M 
TAT GGC TGT AGT TGT GAC CAA CTC CGC GAA CCC TTG ATG 3’ 
 
      A           C   T           A 
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Figure 16. SARS-CoV pseudoknot and attenuator constructs. The minimal constructs 
contained just the SARS-CoV frameshift signal in the dual luciferase vector. The 
extended construct contains the frameshift signal and the upstream attenuator region 
as described by Su et al (2005). An extra base was added to 0 frame constructs so that 
the firefly luciferase gene is in the same reading frame as the renilla luciferase gene. 
  
 
Test (-1 frame) 
renilla/ firefly ratio 
Control (0 frame) 
renilla/ firefly ratio 
Percent 
Frameshifting  
Minimal -1 frame Minimal 0 frame 15.2% 
Extended -1 frame Extended -1 frame 9.68% 
Extended -1 frame Minimal 0 frame 6.57% 
 
Table 1. SARS-CoV attenuator frameshifting. The previous attenuator studies by Su et 
al (2005) calculated frameshifting efficiency by dividing the extended -1 frame by the 




 When the extended construct of both the attenuator and SARS-CoV frameshift 
signal was tested, frameshifting was measured at 9.68%. This was approximately 
60% of wildtype without the attenuator. Therefore, there was a difference observed, 
but not as much as previously reported. 
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Figure 17. Summary of SARS-CoV mutants and constructs.  The fold change of all the 
pseudoknot mutants and constructs are reported as normalized to the wildtype SARS-
CoV frameshifting efficiency. The extended construct with the attenuator region is 
labeled as “fs + attn”. 
 
 
Part 2: Gentamicin’s Influence on Frameshifting 
 Gentamicin is an aminoglycoside antibiotic that binds to the A site of the 
small subunit. Aminoglycosides increase misreading and prevent translocation from 
occurring (Davies & Davis, 1968). Gentamicin and other aminoglycosides stabilize 
the tRNA and mRNA interaction by flipping out the bases A1492 and A1493, which 
mimics cognate tRNA binding (Karimi and Ehrenberg, 1994; Yoshizawa et al, 1998). 
This prohibits proofreading of near-cognate aa-tRNAs. 
 




Figure 18. Binding of gentamicin to the A site of the ribosome. The antibiotic 
gentamicin is shown in red with the rRNA in beige. Interactions between the rRNA 
and gentamicin are highlighted (Yoshizawa et al, 1998). 
 
 
 Gentamicin has been approved for clinical use by the FDA to treat bacterial 
infections. It is also used to prevent microbial contamination in cell culture.  
 Here various amounts of gentamicin were used to culture HeLa CD4+ and 
Jurkat cells. The recommended concentration of gentamicin for use in cell culture is 
50 mg/L (Sigma Aldrich). This was denoted a “1x” concentration, which was tested 
in conjunction with no gentamicin, 0.1x, 0.5x, 5x, and 10x concentrations. The actual 
amounts of gentamicin are reported in the following figures. Furthermore, the read-
through control was also measured at each gentamicin concentration in each cell line, 
and used to calculate the percent frameshifting for individual values.  
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 The frameshifting efficiencies of both HIV and SARS-CoV were measured by 
dual luciferase assays. There was a general trend of increased frameshifting with 
increasing amounts of gentamicin. Overall, HIV frameshifting increased from about 
2.4% without gentamicin to 4% with 500 mg/L of gentamicin in HeLa CD4+ cells. 
SARS-CoV frameshifting increased from 12.8% to 17.2% overall, a total of 4.5% in 
the same cell line. 
 




























Figure 19. Gentamicin affects on frameshifting of HIV and SARS-CoV in HeLa CD4+ 
cells. Error bars denote percent ratiometric standard error. Data was collected in four 
individual experiments until a normal distribution was established, allowing statistical 
analyses across and between experiments (Jacobs & Dinman, 2004). 
 
 
 The same trend was seen in Jurkat cells. HIV and SARS-CoV frameshifting 
increased by approximately 20% with 500 mg/L gentamicin in comparison to a no 
gentamicin control. There is the pattern that frameshifting efficiency increases with 
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increasing amounts of gentamicin. Overall, in both cell lines, there is a total of up to 
1.4-fold increase at the maximum concentration, i.e. an up to 40% increase in 
frameshifting compared to no drug controls. 
 




























Figure 20. Gentamicin affects on frameshifting of HIV and SARS-CoV in Jurkat cells. 
Error bars denote ratiometric standard error. Data was collected in five individual 
experiments until a normal distribution was established, allowing statistical analyses 
across and between experiments (Jacobs & Dinman, 2004). 
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Figure 21. Summary of gentamicin’s effect on frameshifting. Each frameshifting value 
was normalized to the wildtype frameshifting efficiency with no gentamicin in a 
particular cell type.  
 
 
























Figure 22. Percent increase in frameshifting in HeLa CD4+ cells. 
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Figure 23. Percent increase in frameshifting in Jurkat cells. 
 
 
Part 3: Frameshifting in CCR5 
 The human CCR5 gene is expressed in activated CD4+ T cells. The protein 
product is displayed on the surface of the cell and acts as a receptor for various 
chemokines. It is also the co-receptor for HIV, and required for infection. A potential 
frameshift signal was discovered in CCR5 by a computational program that examines 
sequences for potential frameshift signals.  
 The slippery site for CCR5 consists of U UUA AAA, and there is a strong 
downstream pseudoknot. Frameshifting would produce a truncated protein product 
because there is a stop codon in the -1 frame after the frameshift signal. The full 
length CCR5 protein has 352 amino acids, where the frameshift product is predicted 
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to be 226 amino acids. It is not known whether there are separate functions for the 
full length and truncated protein products. 
  The predicted -1 PRF CCR5 signal was cloned into a mammalian dual 
luciferase vector and frameshifting measured in Vero cells. It was found that this 
promoted frameshifting approximately 8.0% of the time. To further validate and 
analyze the frameshift signal, mutants were made that either disrupted the slippery 
site so frameshifting could not occur or disrupted base pairing in stem 2 of the 
pseudoknot. The slippery site was changed from U UUA AAA to C UUG AAG. In 
order to disrupt stem 2, the 5’ side of the stem was mutated to the 3’ side, and vice 
versa. This means the same sequence was on either side of the stem, preventing base 




5’- U UUA AAA GCCAGGACGGUCACC CCCAGGA----AUCUA-CU-----UUACCAGAUCUCAAA --- 3’
 
Figure 24. Structure of the CCR5 frameshift signal. The slippery site is highlighted in 
bold with spacing indicating the incoming reading frame. Stems 1 and 2 are boxed, 
with stem 1 being 5’ in the pseudoknot and stem 2 being 3’, respectively. 
 
 
 Changing the slippery site caused a decrease in frameshifting, as well as 
disrupting stem 2. The slippery site mutant frameshifted 1.3% of the time, which was 
a decrease of 83% over wildtype. The stem 2 5’ mutant had a frameshifting efficiency 
of 1.9%, while the stem 2 3’ was measured at 2.8%. 
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GUCUCU U
CGUUUGUGUCGGUGG-U-- -- GGGUUCACUAGUGUGAACUUACCAGAUCUCAAA
5’- U UUA AAA GCCAGGACGGUCACC CCCAGGA----AUCUA-CU-----UUACCAGAUCUCAAA --- 3’
 





5’- U UUA AAA GCCAGGACGGUCACC CCCAGGA----AUCUA-CU-----AGUGGU---GGGGUUU --- 3’
 






























Figure 27. Frameshifting efficiency in CCR5 constructs. Error bars denote percent 
ratiometric standard error. Data was collected in two individual experiments until a 
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normal distribution was established, allowing statistical analyses across and between 
experiments (Jacobs & Dinman, 2004). 
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Chapter 4: Materials and Methods 
 
 
HIV and SARS-CoV Wildtype Plasmids. 
 
 The SARS-CoV frameshift signal has been cloned into dual luciferase vectors 
as previously described in Plant et al (2005) as both a 0-frame control (pJD464) and a 
-1 test construct (pJD502). The HIV -1 PRF signal (pJD175c) and 0-frame control 
(pJD175d) used for dual luciferase assays in mammalian cells were previously 
reported by Grentzmann et al (1998). 
 
Oligonucleotides, Plasmid Construction and Mutagenesis. 
 The first set of SARS-CoV mutants that included Stem 3 disrupted, Stem 3 
conserved, Assymetric loop 2, Stem 2 Bulge A to C, and Stem 2 disrupted were all 
made previously by Dr. Ewan Plant (Dept. Cell Biology & Molecular Genetics, 
University of Maryland). 
 To generate the other SARS-CoV mutants, oligonucleotide site directed-
mutagenesis was performed. Oligonucleotides were synthesized and purified from 
IDT (Coralville, Iowa). They are listed in Table 1.  
 The mutants L2, S3C, and 2 bp were generated by annealing oligonucleotides 
to the wildtype dual luciferase plasmid, pJD502, and amplified by PCR using the 
Stratagene QuikChange XL10 kit (La Jolla, California). The mutant plasmid, L2, was 
also used as template for generating the S2C* mutant. The mutant S23C used the 
template S2C (pJD473), which was generated previously as described (Plant et al, 
2005).  
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 After the initial changes were made in the SARS-CoV pseudoknot, some 
mutants required the insertion of additional bases to maintain the firefly luciferase 
gene in the -1 frame. This was done through oligonucleotide site-directed 
mutagenesis. S3C had one adenosine inserted immediately 3’ of the pseudoknot by 
use of the “1 base frame” oligonucleotides, as did S23C using the “1 base frame with 
S2C” oligonucleotides. Another construct, 2 bp, needed two adenosines inserted 
downstream of the pseudoknot to maintain the -1 frame, which were inserted using 
the “2 base frame” oligonucleotides. The mutagenesis was performed using the 
Stratagene QuikChange XL10 kit (La Jolla, California) and amplified by PCR. 
 To make the extended constructs of the SARS-CoV attenuator and frameshift 
signal, the attenuator and frameshift region (13222-13520) was amplified by PCR out 
of pJD507 using DNA primers that contained SalI and SacI restriction sites. The 
resulting DNA fragment was digested with restriction enzymes SalI and SacI, as well 
as the mammalian dual luciferase vector pJD175f. These were ligated together and 
transformed into DH5α cells for maintenance and selection by carbenicillin. The 
resulting plasmid contained the attenuator and frameshift region with firefly in the 0 
frame. The test construct with firefly in the -1 frame was produced by inserting an 
adenosine between the attenuator and frameshift signal using the “fs + attn -1” 
oligonucleotides and the Stratagene QuikChange XL10 kit. 
 The CCR5 wildtype construct was generated previously by Trey Belew (Dept. 
Cell Biology & Molecular Genetics, University of Maryland). The subsequent 
plasmid, pJD827, was used as template to make the slippery site, stem 2 5’ 
complement, and stem 2 3’ complement mutants. This was done by oligonucleotide 
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site-directed mutatgenesis using the Stratagene QuikChange XL10 kit and 
amplification by PCR. The slippery site mutant used the “CCR5 slip site” 
oligonucleotides, while the stem 2 5’ and stem 2 3’ used their respective 
oligonucleotides. 
 
Table 2. Oligonucleotides Used in This Study 
Name Sequence 
L2 5’ ccgtcttacaccgtgcggcacaggCTTGcctgatgtcgtctac 3’ 
S3C 5’ gcggcacaggcactagtacTGTgtcgtctacagggcttttgagc 3’ 
S23C 5’ gcggcacaggcactagtacTGTgtcgtctACGggctatttgagc 3’ 
2 bp 5’ gcagcccgtcttacaccgtCGCTTGCGctacagggcttttgagc 3’ 
S2C* 5’ ggCTTGcctgatgtcgtctaCGggctAtttgagctcatggaagacgcc 3” 
1 base frame 5’ cctgtgtcgtctacagggctatttgagctcatggaagacgcc 3’ 
2 base frame 5’ cgtCGCTTGCGctacagggctactttgagctcatggaagacgc 3’ 
1 base frame 
with S2C 
5’ gtacTGTgtcgtctACGggctactttgagctcatggaagacgcc 3’ 
Fs + attn -1 5’ cgtctacagggcttttagagctcgaagacgccagaaaggc 3’ 
CCR5 slip site 5’ cgactgtcgtccatgctgtgtttcggttgaaggccaggacggtcacctttgg 3’ 
CCR5 stem 2 5’ 5’ ccaggacggtcaccaaactctaccattcaagtgtgatcacttgggtggtggc 3’ 
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SARS-CoV and CCR5 Mutant Frameshifting Assays. 
 African green monkey Vero cells were plated at a concentration of 3.0 x 105 
cells/mL in a 24-well plate. The cells were cultured in DMEM supplemented with 
10% FBS and without antibiotics at 37ºC with 5% CO2. The following day the cells 
were transiently transfected with 1 µg of plasmid DNA using 2 µl ExpressFect 
(Denville Scientific) per well following manufacturer’s directions.  
 After 24 hours, Vero cells were washed with PBS and lysed with 1x Passive 
Lysis Buffer (Dual-Luciferase Reporter System, Promega) with gentle rocking for 
fifteen minutes. A Turner 20/20 luminometer was used to measure renilla and firefly 
luciferase activity (Dual-Luciferase Reporter System, Promega, Fitchburg, 
Wisconsin, United States). Transfections were performed in triplicates with at least 
three luciferase readings from each transfection. Data was collected until a normal 
distribution was established, allowing statistical analyses across and between 
experiments (Jacobs & Dinman, 2004). 
 Frameshifting percentage was calculated by dividing the test construct renilla 
to firefly ratio by the control renilla to firefly ratio, and then multiplying by one 
hundred. 
 
Gentamicin Frameshifting Assays. 
 HeLa CD4+ cells were plated at a concentration of 3.0 x 105 cells/mL and 
Jurkats at a concentration of 4.0 x 105 cells/mL in a 24-well plate. The cells were 
cultured in DMEM supplemented with 10% FBS and increasing amounts of 
gentamicin sulfate (Sigma Aldrich) at 37ºC with 5% CO2. The following day the cells 
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were transiently transfected with 1 µg of plasmid DNA using 2 µl ExpressFect 
(Denville Scientific) per well following manufacturer’s directions.  
 After 24 hours, HeLa CD4+ cells were washed with PBS and lysed with 1x 
Passive Lysis Buffer (Dual-Luciferase Reporter System, Promega) with gentle 
rocking for fifteen minutes. Jurkat cells were harvested by centrifugation at 1000x g 
for five minutes. The pellet was washed with PBS, and then cells were lysed by 
resuspension in 1x Passive Lysis Buffer. A Turner 20/20 luminometer was used to 
measure renilla and firefly luciferase activity (Dual-Luciferase Reporter System, 
Promega, Fitchburg, Wisconsin, United States). The read-through control and the test 
construct were measured at each of the gentamicin concentrations. Transfections were 
performed in triplicates per amount of gentamicin used with at least three luciferase 
readings from each transfection. Data was collected until a normal distribution was 
established, allowing comparison across and between experiments. 
 Frameshifting percentage was calculated by dividing the test construct renilla 
to firefly ratio at a specific gentamicin concentration by the control renilla to firefly 
ratio at the same gentamicin concentration, and then multiplying by one hundred. 
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Chapter 5:  Discussion 
 
 
Part 1: SARS-CoV Frameshifting 
 A series of mutants were made to investigate the important features of the 
SARS-CoV pseudoknot, as evidenced in Figure 10. Disruption of Stem 2 resulted in 
nearly abolished frameshifting. The base pairing of stem 3 was disrupted and then re-
established with different base pairs. When there was no base pairing in stem 3, 
frameshifting was significantly decreased. However, after reforming the stem with a 
new sequence, frameshifting was only a third of wildtype. This suggests that the 
sequence of stem 3 is important for frameshifting efficiency, and not just the structure 
of stem 3 itself. Moreover, when stem 3 was shortened from nine base pairs to only 
two base pairs and loop 2 was mutated to a tetraloop, as in the 2 bp mutant, 
frameshifting was measured at 13%. This is about 80% of wildtype. In this construct, 
the importance of the stem 3 sequence for frameshifting could be off set by the 
increased stability of the shortened stem with a tetraloop, as it has previously been 
known that increased mRNA stability leads to increased frameshifting (Namy et al, 
2006).  
 Loop 2 was mutated to an asymmetric loop. Frameshifting decreased to 30% 
of wildtype. Also, loop 2 was mutated to a tetraloop that would increase the stability 
and frameshifting also increased by 2% as a result (Figure 13). It is interesting to note 
that there is the possibility of loop 2 to form a kissing loop interaction with another 
loop 2, as referenced in Figure 12. Both the asymmetric loop and the L2* construct 
 
 49  
would prevent this possible interaction. In the case of L2*, the increased stability of 
the tetraloop could balance out the detrimental effects of preventing the kissing loop 
interaction. However, it is also possible that the bases mutated to form the 
asymmetric loop were themselves important for frameshifting. It has not yet been 
shown whether this kissing loop interaction actually takes place in vivo or whether it 
is truly important for frameshifting. Further experiments need to be done to determine 
this. 
 Another interesting feature of the SARS-CoV pseudoknot is the two unpaired 
adenosines in stem 2 and stem 3. These have been hypothesized to be important for 
frameshifting efficiency. When the stem 2 bulged A was mutated to a C or deleted, 
frameshifting dropped to between one and two percent (Plant et al, 2005). When both 
bulged As were deleted, frameshifting decreased to a similar level. On the other hand, 
when the stem 3 unpaired adenosine was singularly deleted, frameshifting actually 
increased. This can be seen in Figure 13. Overall, it seems that the stem 2 bulged A is 
important for frameshifting efficiency and certainly more important than the stem 3 
bulged A.  
 This is further validated by the construct S2C*, in which loop 2 is mutated to 
a stable tetraloop and the stem 2 unpaired adenosine is deleted. The frameshifting 
efficiency was measured at 13%, similar to wildtype. The increased stability of the 
mRNA from the tetraloop could off set the decrease in frameshifting caused by the 
deleted bulge A.  
 Further mutational analyses should be done to validate these findings. 
Suggested constructs are drawn below in Figure 29. S3C* would look at the stem 3 
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unpaired adenosine and mRNA stability with the tetraloop. S23C* would have both 
unpaired adenosines deleted and have loop 2 mutated to a tetraloop. Finally, 
S3_4bp_UUCG would have a shortened stem 3 with only four base pairs compared to 
the wildtype stem 3 with 9 base pairs, and have a tetraloop. This would increase the 
mRNA stability of the pseudoknot. Also, part of the sequence of stem 3 would be 
conserved in S3_4bp_UUCG, looking at what bases are important for frameshifting 
efficiency. 
    
Figure 29. Suggested additional mutants of the SARS-CoV pseudoknot. These 
constructs further investigate the importance of the unpaired adenosines, mRNA 
stability, the possible kissing loop interaction, and the sequence of stem 3.  
 
 One study had shown that there was a possible upstream attenuator region in 
the SARS-CoV genome. The attenuator is a highly structured region that is 
approximately 150 bases upstream from the frameshift signal. It was found that when 
this region is included in constructs looking at frameshifting efficiency, frameshifting 
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decreased by 50%. When this experiment was repeated, frameshifting was 60% of the 
wildtype level without the attenuator region.  
 How, and if, the attenuator actually impacts frameshifting remains to be 
investigated. It could be that the attenuator is interacting with the ribosome or 
pseudoknot directly, or a protein factor is binding and affecting frameshifting. 
However, it could be that the attenuator is acting as a “translational speed bump,” 
where ribosomes are falling off when translating the mRNA due to the secondary 
structure. The upstream reporter would be consistently translated, but the downstream 
reporter would be translated less, which would look like a decrease in frameshifting 
efficiency. This could be examined by mutating the attenuator region by disrupting 
base pairing, shown in Figure30. Reducing the secondary structure could keep more 
ribosomes on, and also look at whether the structure or nucleotide sequence is 
important. 
 
Figure 30. Suggested mutations in the SARS-CoV attenuator region. The bases that 
are circled in red are bases that can be mutated to disrupt base pairing while 
maintaining the same amino acid sequence. 
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 From the mutants already made, it can be determined that the important 
features of the SARS-CoV pseudoknot include: the sequence of stem 3, loop 2, and 
the stem 2 bulged A. Future work should investigate the existence of the kissing loop 
interaction of loop 2 or base pairing between SARS-CoV pseudoknots should be 
investigated. It would also be informative to separate the disruption of the possible 
kissing loops with mRNA stability, and to study these individually.  
 
Part 2: Gentamicin’s Influence on Frameshifting 
 Aminoglycosides are antibiotics that bind to the A site of the ribosome. These 
can decrease translational fidelity by stabilizing near-cognate binding in the A site, 
and also increase programmed ribosomal frameshifting by stabilizing base pairing in 
the -1 frame. Moreover, disrupting frameshifting efficiency can have dramatic 
impacts on viral propagation (Dinman & Wickner, 1992; Léger et al, 2007).  
 When the aminoglycoside gentamicin was added to media in increasing 
concentrations, the frameshifting efficiency of both HIV-1 and SARS-CoV increased 
over a no gentamicin control. There was a 1.4-fold increase in HIV frameshifting in 
HeLa CD4+ cells with 500mg/L gentamicin, shown in Figure 19. SARS-CoV 
frameshifting increased from about 12.5% to 17.5%. In Jurkat cells, HIV 
frameshifting increased 34% and SARS-CoV increased by 32% compared to without 
gentamicin (Figure 20). Overall, with increasing gentamicin concentrations there is 
increasing ribosomal frameshifting. 
 This study is in collaboration with other laboratories who are investigating 
gentamicin’s effect on viral propagation. HIV results correlated well with the 
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frameshifting assays. As the efficiency of frameshifting increased, infectivity 
decreased. This was measured by reverse transcriptase assays and viral titers.  
 Gentamicin is a drug approved by the FDA to treat bacterial infections. About 
ten percent of the population experience major side effects that include problems with 
kidneys and the inner ear. Physicians typically prescribe a dose of 5-7 mg/kg, which 
is about twice the maximum concentration of gentamicin used in the frameshifting 
and viral propagation studies.  
 Gentamicin, then, could theoretically be used as a new treatment for HIV. It is 
safe for most of the human population and decreases viral titer. Gentamicin decreases 
translational fidelity, and is supposed to be specific to bacterial ribosomes. However, 
this study saw an effect with eukaryotic ribosomes in cell culture. 
 Further investigation into using gentamicin clinically needs to be done. Other 
aminoglycosides should also be examined. This study has pointed out a specific 
binding site that could be used as an antiviral target. 
 Another facet of this study is the different mechanisms that frameshifting 
affects. In HIV, changing the frameshifting efficiency causes assembly defects, due to 
the different stoichiometry between gag, the structural protein, and pol, the enzymatic 
proteins. However, in SARS-CoV, the frameshift signal controls the ratio between 
different enzymatic proteins. It is not fully understood how changing the 
frameshifting efficiency effects viral propagation. This is something that needs to be 
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Part 3: Frameshifting in CCR5 
 CCR5 is a human chemokine receptor that is present on the surface of several 
types of immune cells. It is also the co-receptor of HIV, and required for entry of the 
virus into the cell. A frameshift signal was predicted to be located within the human 
gene of CCR5. When this was cloned into a dual luciferase reporter, it was found that 
the -1 PRF signal was functional.  
 Further mutational analysis was done to validate the frameshift signal. The 
slippery site was mutated from U UUU AAA to C UUG AAG. This prevents base 
pairing in the -1 frame so frameshifting cannot occur. Also, stem 2 was disrupted by 
mutating the 5’ side of the stem to the 3’ side (Figure 25). That means the same 
sequence was on each side of the stem, completely preventing base pairing. This was 
also done to the 3’ side (Figure 26). By disrupting stem 2, the stability of the 
pseudoknot decreases and thus frameshifting decreases.  
 Future studies should include other mutants to examine the CCR5 frameshift 
signal. Stem 1 should be disrupted in the same way that stem 2 was, as shown in 
Figure 31. Also, compensatory mutations should be made that restore base pairing in 
the stem, but reverse the sequence. For example, the wildtype 5’ sequence should be 
on the 3’ side and the 3’ sequence on the 5’ side. This will determine if the structure 
itself or the sequence is important for frameshifting efficiency. This should be done 
for both stem 1 and stem 2. 
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GUCUCU U
CGUUUGUACGGUCACC-U-- -- GGGUUCACUAGUGUGAACAGUGGU---GGGGUUU















5’- U UUA AAA GCCAGGACGGUCACC CCCAGGA----AUCUA-CU-----AGUGGU---GGGGUUU --- 3’
Stem 2 compensatory
Figure 31. Suggested further studies on the CCR5 frameshift signal. Stem 1 and 2 are 
boxed, and the slippery site is in bold. Stem 1 is closer to the slippery site. Stem 1 
should be disrupted and both stems should have compensatory mutations. Also, the 
structure of the CCR5 pseudoknot should be confirmed. 
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 Furthermore, the structure of the CCR5 pseudoknot has only been predicted 
by computational mRNA folding programs. There is some secondary structure there 
because frameshifting occurs. However, the exact interactions are only predicted. The 
most likely structure as seen in Figure 23 is may not be the physiological structure. 
There is no spacer region, which is required so that the slippery site is positioned in 
the A and P sites of the ribosome. The lower part of stem 1 is likely unwound by the 
ribosome, similar to the HIV stem loop. The actual structure should be examined by 
structure probing and nuclease mapping. 
 The biological impact and significance of CCR5 frameshifting remains to be 
investigated. When CCR5 frameshifts, it produces a truncated protein product. The 
N-terminal 138 amino acids are the same in both the full length and truncated protein. 
The N-terminal is responsible for the binding to the HIV glycoprotein. It is not known 
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Figure 32. Structure of CCR5 protein in the cell membrane. Interaction with the HIV 
gp120 is with the N-terminal end and extracellular loop 2 (ECL2) (Huang et al, 
2007). The 138 N-terminal amino acids are common in both the full length and 
truncated frameshift products. 
 
 
 If the frameshift product is indeed on the cell surface, it could be influential in 
HIV pathogenesis. Once CCR5 is bound by the HIV glycoprotein, HIV gp41 
undergoes a conformational rearrangement and the membranes can fuse. Whether 
HIV could bind both CCR5 products or binds one preferentially over the other needs 
to be determined. This could be a potential target in treating HIV infections. 
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